Once a COVID-19 vaccine is approved, the Centers for Medicare and Medicaid Services (CMS) will make it available to seniors at no cost.

Johnson and Johnson is the second pharmaceutical company to have to pause a phase 3 clinical trial for a COVID vaccine.

Health care was one of many topics that the two candidates for vice-president did not agree on.

Proving yet again that necessity fuels invention, some hospital systems and insurers, normally not the best of friends, have decided that working together makes more sense than not to bring about...

Some COVID-19 products don't always match their advertising claims. Since the pandemic started in March, the FDA has issued 120 COVID-19-related warning letters.

If the Affordable Care Act (ACA) is overturned, almost every American will feel the effect in some way, according to an analysis by the Kaiser Family Foundation.

Telehealth is having a moment that has been decades in the making.

New research finds disparities in testing, infections, and outcomes for Black and Hispanic Americans

Despite close quarters, high levels of perspiration and possible coronavirus contamination, many schools and colleges have decided: We should go forward with in-person sports. 

A physician in Cleveland wants researchers and the media to recognize that when they write about overdoses and firearm deaths among young people, that they are writing about people, not statistics.

Purdue, maker of prescription opioids, is still in trouble as 49 states file for $2.2 trillion for the company's role in the opioid epidemic.

News from August 17: Doubts about temperature as an early COVID-19 symptom, new spit test could replace swab testing for the virus, and NZ postpones election due to spike in cases.